- Filed
- Nov 12, 2020 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Nov 4, 2020 | 114.66M sh |
| Cash And Equivalents | Q3 2020 · Sep 30, 2020 | $1.13M |
| Cash And Equivalents | Q3 2020 · Dec 31, 2019 | $2.03M |
| Current Liabilities | Q3 2020 · Sep 30, 2020 | $3.16M |
| Current Liabilities | Q3 2020 · Dec 31, 2019 | $4.22M |
| Total Liabilities | Q3 2020 · Sep 30, 2020 | $92.62M |
| Total Liabilities | Q3 2020 · Dec 31, 2019 | $91.48M |
| Current Assets | Q3 2020 · Sep 30, 2020 | $7.5M |
| Current Assets | Q3 2020 · Dec 31, 2019 | $9.28M |
| Total Assets | Q3 2020 · Sep 30, 2020 | $12.77M |
| Total Assets | Q3 2020 · Dec 31, 2019 | $19.42M |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 103.79M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 97.21M sh |
| Capex | Q3 2020 · Sep 30, 2019 | $27K |
| Operating Cash Flow | Q3 2020 · Sep 30, 2019 | −$5.22M |
| Stockholders Equity | Q3 2020 · Sep 30, 2019 | −$70.95M |
| Stockholders Equity | Q3 2020 · Jun 30, 2019 | −$69.12M |
| Stockholders Equity | Q3 2020 · Dec 31, 2018 | −$62.96M |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | −$0.03 |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | −$0.09 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | −$0.03 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | −$0.09 |
| Net Income | Q3 2020 · Sep 30, 2019 | −$2.81M |
| Net Income | Q3 2020 · Sep 30, 2019 | −$9.11M |
| Operating Income | Q3 2020 · Sep 30, 2019 | −$1.83M |
| Operating Income | Q3 2020 · Sep 30, 2019 | −$5.36M |
| Cost Of Revenue | Q3 2020 · Sep 30, 2019 | $13.87M |
| Cost Of Revenue | Q3 2020 · Sep 30, 2019 | $42.49M |
| Revenue | Q3 2020 · Sep 30, 2019 | $15.67M |
| Revenue | Q3 2020 · Sep 30, 2019 | $47.82M |